Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00401-013-1200-z.

Title:
C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci | Acta Neuropathologica
Description:
An expanded GGGGCC repeat in a non-coding region of the C9orf72 gene is a common cause of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis. Non-coding repeat expansions may cause disease by reducing the expression level of the gene they reside in, by producing toxic aggregates of repeat RNA termed RNA foci, or by producing toxic proteins generated by repeat-associated non-ATG translation. We present the first definitive report of C9orf72 repeat sense and antisense RNA foci using a series of C9FTLD cases, and neurodegenerative disease and normal controls. A sensitive and specific fluorescence in situ hybridisation protocol was combined with protein immunostaining to show that both sense and antisense foci were frequent, specific to C9FTLD, and present in neurons of the frontal cortex, hippocampus and cerebellum. High-resolution imaging also allowed accurate analyses of foci number and subcellular localisation. RNA foci were most abundant in the frontal cortex, where 51 % of neurons contained foci. RNA foci also occurred in astrocytes, microglia and oligodendrocytes but to a lesser degree than in neurons. RNA foci were observed in both TDP-43- and p62-inclusion bearing neurons, but not at a greater frequency than expected by chance. RNA foci abundance in the frontal cortex showed a significant inverse correlation with age at onset of disease. These data establish that sense and antisense C9orf72 repeat RNA foci are a consistent and specific feature of C9FTLD, providing new insight into the pathogenesis of C9FTLD.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Mobile Technology & AI

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

We can't tell how the site generates income.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {πŸ”}

foci, rna, sense, antisense, cftld, fig, cases, neurons, frontal, cortex, article, corf, case, neuron, hippocampus, google, scholar, brain, pubmed, repeat, cerebellum, homozygous, cell, inclusions, fish, heterozygous, cas, tdp, shown, frontotemporal, neuronal, disease, quantification, specific, observed, cytoplasmic, regions, number, nucleus, present, dementia, type, probe, image, granule, red, ggggcc, age, expansion, performed,

Topics {βœ’οΈ}

chromosome 9p21-linked als-ftd chromosome 9p-linked ftd article download pdf cac-tip-ptd-p01 frontotemporal lobar degeneration depth clinico-pathological examination aggregating dipeptide-repeat proteins amyotrophic lateral sclerosis 7Β ΞΌm-thick paraffin sections ipsc-derived human neurons high-resolution confocal imaging 2β€²-o-methyl rna probes 2β€²-o-methyl rna probe atg-initiated translation directed high-stringency wash solution c9orf72 expansion carriers multiple neurodegenerative syndromes c9orf72 repeat expansion hexanucleotide repeat expansion tdp-43-positive cytoplasmic inclusions c9orf72 hexanucleotide repeat full access privacy choices/manage cookies related subjects c9orf72-linked ftld reveals total foci oligodendrocyte marker caii c9orf72 ggggcc repeat article mizielinska cohn-hokke pe high-resolution imaging g-quadruplex structure [11] p62-inclusion bearing neurons expanded ggggcc repeat phenomenon termed repeat expanded repeat rna original author c9orf72 repeat sense high melting temperature producing toxic aggregates 8Β mg/ml trna neuronal rna foci coding repeat expansions author information authors graphpad prism software stranded structure termed small size pre-hybridisation solution toxic rna hypothesis research uk

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci
         description:An expanded GGGGCC repeat in a non-coding region of the C9orf72 gene is a common cause of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis. Non-coding repeat expansions may cause disease by reducing the expression level of the gene they reside in, by producing toxic aggregates of repeat RNA termed RNA foci, or by producing toxic proteins generated by repeat-associated non-ATG translation. We present the first definitive report of C9orf72 repeat sense and antisense RNA foci using a series of C9FTLD cases, and neurodegenerative disease and normal controls. A sensitive and specific fluorescence in situ hybridisation protocol was combined with protein immunostaining to show that both sense and antisense foci were frequent, specific to C9FTLD, and present in neurons of the frontal cortex, hippocampus and cerebellum. High-resolution imaging also allowed accurate analyses of foci number and subcellular localisation. RNA foci were most abundant in the frontal cortex, where 51Β % of neurons contained foci. RNA foci also occurred in astrocytes, microglia and oligodendrocytes but to a lesser degree than in neurons. RNA foci were observed in both TDP-43- and p62-inclusion bearing neurons, but not at a greater frequency than expected by chance. RNA foci abundance in the frontal cortex showed a significant inverse correlation with age at onset of disease. These data establish that sense and antisense C9orf72 repeat RNA foci are a consistent and specific feature of C9FTLD, providing new insight into the pathogenesis of C9FTLD.
         datePublished:2013-10-30T00:00:00Z
         dateModified:2013-10-30T00:00:00Z
         pageStart:845
         pageEnd:857
         sameAs:https://doi.org/10.1007/s00401-013-1200-z
         keywords:
            FTLD
            FTD
            ALS
            RNA foci
            Antisense
             C9orf72
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig8_HTML.gif
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:126
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sarah Mizielinska
               affiliation:
                     name:UCL Institute of Neurology
                     address:
                        name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tammaryn Lashley
               affiliation:
                     name:UCL Institute of Neurology
                     address:
                        name:Department of Molecular Neuroscience, Queen Square Brain Bank, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frances E. Norona
               affiliation:
                     name:UCL Institute of Neurology
                     address:
                        name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Emma L. Clayton
               affiliation:
                     name:UCL Institute of Neurology
                     address:
                        name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Charlotte E. Ridler
               affiliation:
                     name:UCL Institute of Neurology
                     address:
                        name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pietro Fratta
               affiliation:
                     name:UCL Institute of Neurology
                     address:
                        name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
                     name:UCL Institute of Neurology
                     address:
                        name:MRC Centre for Neuromuscular Disease, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Adrian M. Isaacs
               affiliation:
                     name:UCL Institute of Neurology
                     address:
                        name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci
      description:An expanded GGGGCC repeat in a non-coding region of the C9orf72 gene is a common cause of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis. Non-coding repeat expansions may cause disease by reducing the expression level of the gene they reside in, by producing toxic aggregates of repeat RNA termed RNA foci, or by producing toxic proteins generated by repeat-associated non-ATG translation. We present the first definitive report of C9orf72 repeat sense and antisense RNA foci using a series of C9FTLD cases, and neurodegenerative disease and normal controls. A sensitive and specific fluorescence in situ hybridisation protocol was combined with protein immunostaining to show that both sense and antisense foci were frequent, specific to C9FTLD, and present in neurons of the frontal cortex, hippocampus and cerebellum. High-resolution imaging also allowed accurate analyses of foci number and subcellular localisation. RNA foci were most abundant in the frontal cortex, where 51Β % of neurons contained foci. RNA foci also occurred in astrocytes, microglia and oligodendrocytes but to a lesser degree than in neurons. RNA foci were observed in both TDP-43- and p62-inclusion bearing neurons, but not at a greater frequency than expected by chance. RNA foci abundance in the frontal cortex showed a significant inverse correlation with age at onset of disease. These data establish that sense and antisense C9orf72 repeat RNA foci are a consistent and specific feature of C9FTLD, providing new insight into the pathogenesis of C9FTLD.
      datePublished:2013-10-30T00:00:00Z
      dateModified:2013-10-30T00:00:00Z
      pageStart:845
      pageEnd:857
      sameAs:https://doi.org/10.1007/s00401-013-1200-z
      keywords:
         FTLD
         FTD
         ALS
         RNA foci
         Antisense
          C9orf72
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1200-z/MediaObjects/401_2013_1200_Fig8_HTML.gif
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:126
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sarah Mizielinska
            affiliation:
                  name:UCL Institute of Neurology
                  address:
                     name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tammaryn Lashley
            affiliation:
                  name:UCL Institute of Neurology
                  address:
                     name:Department of Molecular Neuroscience, Queen Square Brain Bank, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frances E. Norona
            affiliation:
                  name:UCL Institute of Neurology
                  address:
                     name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Emma L. Clayton
            affiliation:
                  name:UCL Institute of Neurology
                  address:
                     name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Charlotte E. Ridler
            affiliation:
                  name:UCL Institute of Neurology
                  address:
                     name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pietro Fratta
            affiliation:
                  name:UCL Institute of Neurology
                  address:
                     name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
                  name:UCL Institute of Neurology
                  address:
                     name:MRC Centre for Neuromuscular Disease, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Adrian M. Isaacs
            affiliation:
                  name:UCL Institute of Neurology
                  address:
                     name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:126
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:UCL Institute of Neurology
      address:
         name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
         type:PostalAddress
      name:UCL Institute of Neurology
      address:
         name:Department of Molecular Neuroscience, Queen Square Brain Bank, UCL Institute of Neurology, London, UK
         type:PostalAddress
      name:UCL Institute of Neurology
      address:
         name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
         type:PostalAddress
      name:UCL Institute of Neurology
      address:
         name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
         type:PostalAddress
      name:UCL Institute of Neurology
      address:
         name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
         type:PostalAddress
      name:UCL Institute of Neurology
      address:
         name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
         type:PostalAddress
      name:UCL Institute of Neurology
      address:
         name:MRC Centre for Neuromuscular Disease, UCL Institute of Neurology, London, UK
         type:PostalAddress
      name:UCL Institute of Neurology
      address:
         name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sarah Mizielinska
      affiliation:
            name:UCL Institute of Neurology
            address:
               name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
      name:Tammaryn Lashley
      affiliation:
            name:UCL Institute of Neurology
            address:
               name:Department of Molecular Neuroscience, Queen Square Brain Bank, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
      name:Frances E. Norona
      affiliation:
            name:UCL Institute of Neurology
            address:
               name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
      name:Emma L. Clayton
      affiliation:
            name:UCL Institute of Neurology
            address:
               name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
      name:Charlotte E. Ridler
      affiliation:
            name:UCL Institute of Neurology
            address:
               name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
      name:Pietro Fratta
      affiliation:
            name:UCL Institute of Neurology
            address:
               name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
            name:UCL Institute of Neurology
            address:
               name:MRC Centre for Neuromuscular Disease, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
      name:Adrian M. Isaacs
      affiliation:
            name:UCL Institute of Neurology
            address:
               name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
      name:Department of Molecular Neuroscience, Queen Square Brain Bank, UCL Institute of Neurology, London, UK
      name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
      name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
      name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
      name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
      name:MRC Centre for Neuromuscular Disease, UCL Institute of Neurology, London, UK
      name:Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK

External Links {πŸ”—}(120)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.6s.